Pfizer says indirect purchasers can't yet appeal order in US EpiPen antitrust suit
MLex Summary: Pfizer filed a brief opposing indirect purchasers’ request for immediate appeal of a decision that dismissed their US claims that Pfizer conspired to delay generic EpiPen, saying they cannot...To view the full article, register now.
Already a subscriber? Click here to view full article